检索结果 - Koos de Wit

  • Showing 1 - 4 results of 4
Refine Results
  1. 1
    Opt-In and Opt-Out Consent Procedures for the Reuse of Routinely Recorded Health Data in Scientific Research and Their Consequences for Consent Rate and Consent Bias: Systematic Review

    Opt-In and Opt-Out Consent Procedures for the Reuse of Routinely Recorded Health Data in Scientific Research and Their Consequences for Consent Rate and Consent Bias: Systematic Re... 由 Yvonne de Man, Yvonne Wieland-Jorna, Bart Torensma, Koos de Wit, Anneke L. Francke, Mariska Oosterveld‐Vlug, Robert Verheij

    出版 2023
    获取全文 获取全文
    Revisão
    加到收藏夹
    Saved in:
  2. 2
    The Use of Rifaximin in Patients With Cirrhosis

    The Use of Rifaximin in Patients With Cirrhosis 由 Paolo Caraceni, Vı́ctor Vargas, Elsa Solà, Carlo Alessandria, Koos de Wit, Jonel Trebicka, Paolo Angeli, Rajeshwar P. Mookerjee, François Durand, Elisa Pose, Aleksander Krag, Jasmohan S. Bajaj, Ulrich Beuers, Pere Ginès

    出版 2021
    获取全文 获取全文
    Revisão
    加到收藏夹
    Saved in:
  3. 3
    Prevention of hepatic encephalopathy by administration of rifaximin and lactulose in patients with liver cirrhosis undergoing placement of a transjugular intrahepatic portosystemic shunt (TIPS): a multicentre randomised, double blind, placebo controlled trial (PEARL trial)

    Prevention of hepatic encephalopathy by administration of rifaximin and lactulose in patients with liver cirrhosis undergoing placement of a transjugular intrahepatic portosystemic... 由 Koos de Wit, Jelte J. Schaapman, Frederik Nevens, Jef Verbeek, Samuel Coenen, Frans J.C. Cuperus, M. Kramer, Eric T.T.L. Tjwa, Nahid Mostafavi, M.G.W. Dijkgraaf, Otto M. van Delden, Ulrich Beuers, Minneke J. Coenraad, R. Bart Takkenberg

    出版 2020
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  4. 4
    Safety of two different doses of simvastatin plus rifaximin in decompensated cirrhosis (LIVERHOPE-SAFETY): a randomised, double-blind, placebo-controlled, phase 2 trial

    Safety of two different doses of simvastatin plus rifaximin in decompensated cirrhosis (LIVERHOPE-SAFETY): a randomised, double-blind, placebo-controlled, phase 2 trial 由 Elisa Pose, Laura Napoleone, Ahmed Adel Amin, Daniela Campion, César Jimenez, Salvatore Piano, Olivier Roux, Frank Erhard Uschner, Koos de Wit, Giacomo Zaccherini, Carlo Alessandria, Paolo Angeli, Mauro Bernardi, Ulrich Beuers, Paolo Caraceni, François Durand, Rajeshwar P. Mookerjee, Jonel Trebicka, Vı́ctor Vargas, Raúl J. Andrade, Marta Carol, Judit Pich, Juan Pablo Ferrero, Gema Doménech, Marta Llopis, Ferràn Torres, Patrick S. Kamath, Juan G. Abraldeṣ, Elsa Solà, Pere Ginès

    出版 2019
    获取全文
    Artigo
    加到收藏夹
    Saved in:

检索工具: